A panel of FDA advisers voted in favor of approving the HeartWare ventricular assist device, a blood pump tailored for use in severe heart failure patients awaiting transplants. The panel concluded that the device was helpful in saving lives, but urged HeartWare to run additional safety studies if it obtains FDA approval.

Full Story:

Related Summaries